Related references
Note: Only part of the references are listed.A direct, sensitive and efficient method for determination of alpha-fluoro-beta-alanine in urine: Evaluating the influence of magnesium isoglycyrrhizinate on excretion in rat model
Zhipeng Wang et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2018)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Incidence and mortality of colorectal cancer in China, 2011
Shuzheng Liu et al.
CHINESE JOURNAL OF CANCER RESEARCH (2015)
Pharmacokinetics and exposure-effect relationships of capecitabine in elderly patients with breast or colorectal cancer
Z. Daher Abdi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Evaluation of Clinical Value of Single Nucleotide Polymorphisms of Dihydropyrimidine Dehydrogenase Gene to Predict 5-Fluorouracil Toxicity in 60 Colorectal Cancer Patients in China
Xin Zhang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2013)
Quantitative determination of capecitabine and its six metabolites in human plasma using liquid chromatography coupled to electrospray tandem mass spectrometry
Maarten J. Deenen et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
Evaluation of 5-fluorouracil pharmacokinetic models and therapeutic drug monitoring in cancer patients
Andre B. P. van Kuilenburq et al.
PHARMACOGENOMICS (2013)
Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity
Ursula Amstutz et al.
PHARMACOGENOMICS (2011)
Capecitabine in the management of colorectal cancer
S. Yousuf Zafar et al.
Cancer Management and Research (2011)
A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5 '-deoxy-5-fluorocytidine, 5 '-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma
Liia D. Vainchtein et al.
BIOMEDICAL CHROMATOGRAPHY (2010)
An APCI LC-MS/MS method for routine determination of capecitabine and its metabolites in human plasma
Damien Montange et al.
JOURNAL OF MASS SPECTROMETRY (2010)
Thymidine Phosphorylase to Dihydropyrimidine Dehydrogenase Ratio as a Predictive Factor of Response to Preoperative Chemoradiation With Capecitabine in Patients With Advanced Rectal Cancer
C. S. Boskos et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Drug exposure: still an excellent biomarker
Judith Meza-Junco et al.
BIOMARKERS IN MEDICINE (2009)
Development of a sensitive and selective LC-MS/MS method for the determination of α-fluoro-β-alanine, 5-fluorouracil and capecitabine in human plasma
Hermes Licea-Perez et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Simultaneous LC-MS-MS analysis of capecitabine and its metabolites (5′-deoxy-5-fluorocytidine, 5′-deoxy-5-fluorouridine, 5-fluorouracil) after off-line SPE from human plasma
A. Salvador et al.
CHROMATOGRAPHIA (2006)
Simultaneous determination of capecitabine and its metabolite 5-fluorouracil by column switching and liquid chromatographic/tandem mass spectrometry
C Siethoff et al.
JOURNAL OF MASS SPECTROMETRY (2004)
Clinical pharmacokinetics of capecitabine
B Reigner et al.
CLINICAL PHARMACOKINETICS (2001)
Share Paper
